Clopidogrel Bisulfate ((S)-(+)-Clopidogrel bisulfate, (S)-(+)-Clopidogrel hydrogen sulfate, SR-25990C)，又称硫酸氢氯吡格雷，是一种口服的噻吩吡啶类抗血小板药物，抑制ADP诱导的血小板聚集，可防止血栓形成，临床上用于治疗缺血性中风、心肌梗死以及血管疾病。

参考文献

1.Katsunobu Hagihara, et al. Comparison of human cytochrome P450 inhibition by the thienopyridines prasugrel, Clopidogrel, and ticlopidine. Drug Metab Pharmacokinet. 2008;23(6):412-20.

2.Jean-Marc Herbert, et al. P2Y12, a new platelet ADP receptor, target of Clopidogrel.Semin Vasc Med. 2003 May;3(2):113-22.

3.Hai-Lu Wu, et al. Increased endoplasmic reticulum stress response is involved in Clopidogrel-induced apoptosis of gastric epithelial cells. PLoS One. 2013 Sep 13;8(9):e74381.

4.Ran Ni, et al. Effect of Different Doses of Acetylsalicylic Acid on the Antithrombotic Activity of Clopidogrel in a Mouse Arterial Thrombosis Model.Arterioscler Thromb Vasc Biol. 2018 Oct;38(10):2338-2344.

冰袋运输。粉末直接保存于-20℃，有效期3年。建议分装后-20℃干燥保存，避免反复冻融。